Nike Appoints Pfizer CFO David M. Denton as Chief Financial Officer, Stock Rises 2%

Nike appointed David M. Denton, former chief financial officer of Pfizer Pharmaceuticals, as its new chief financial officer, effective August 17. The appointment was announced after hours today, and Nike's stock rose 2% in after-hours trading.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments